Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

Cited In for PubMed (Select 2443238)

1.

Expression of CC chemokine receptor 5 in clear cell renal cell carcinoma and its clinical significance.

Yoo KH, Lee DG, Won KY, Lim SJ, Park YK, Chang SG.

Oncol Lett. 2015 May;9(5):2085-2089. Epub 2015 Mar 17.

2.

DNA methylation as a dynamic regulator of development and disease processes: spotlight on the prostate.

Keil KP, Vezina CM.

Epigenomics. 2015;7(3):413-25. doi: 10.2217/epi.15.8.

PMID:
26077429
3.

Bone marrow stromal antigen 2 (BST-2) DNA is demethylated in breast tumors and breast cancer cells.

Mahauad-Fernandez WD, Borcherding NC, Zhang W, Okeoma CM.

PLoS One. 2015 Apr 10;10(4):e0123931. doi: 10.1371/journal.pone.0123931. eCollection 2015.

4.

Effects of sulforaphane and 3,3'-diindolylmethane on genome-wide promoter methylation in normal prostate epithelial cells and prostate cancer cells.

Wong CP, Hsu A, Buchanan A, Palomera-Sanchez Z, Beaver LM, Houseman EA, Williams DE, Dashwood RH, Ho E.

PLoS One. 2014 Jan 22;9(1):e86787. doi: 10.1371/journal.pone.0086787. eCollection 2014.

5.

Role of gene methylation in antitumor immune response: implication for tumor progression.

Serrano A, Castro-Vega I, Redondo M.

Cancers (Basel). 2011 Mar 29;3(2):1672-90. doi: 10.3390/cancers3021672.

6.

Epigenetic susceptibility factors for prostate cancer with aging.

Damaschke NA, Yang B, Bhusari S, Svaren JP, Jarrard DF.

Prostate. 2013 Dec;73(16):1721-30. doi: 10.1002/pros.22716. Epub 2013 Sep 2. Review.

7.

Epigenomic alterations in localized and advanced prostate cancer.

Lin PC, Giannopoulou EG, Park K, Mosquera JM, Sboner A, Tewari AK, Garraway LA, Beltran H, Rubin MA, Elemento O.

Neoplasia. 2013 Apr;15(4):373-83.

8.

DNA methylation in the malignant transformation of meningiomas.

Gao F, Shi L, Russin J, Zeng L, Chang X, He S, Chen TC, Giannotta SL, Weisenberger DJ, Zada G, Mack WJ, Wang K.

PLoS One. 2013;8(1):e54114. doi: 10.1371/journal.pone.0054114. Epub 2013 Jan 22.

9.

Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression.

Lee JH, Khor TO, Shu L, Su ZY, Fuentes F, Kong AN.

Pharmacol Ther. 2013 Feb;137(2):153-71. doi: 10.1016/j.pharmthera.2012.09.008. Epub 2012 Oct 3. Review.

10.

Emerging putative biomarkers: the role of alpha 2 and 6 integrins in susceptibility, treatment, and prognosis.

Marthick JR, Dickinson JL.

Prostate Cancer. 2012;2012:298732. doi: 10.1155/2012/298732. Epub 2012 Jul 31.

11.

Genetic and epigenetic changes in human prostate cancer.

Koochekpour S.

Iran Red Crescent Med J. 2011 Feb;13(2):80-98. Epub 2011 Feb 1.

12.

Epigenetic regulation of prostate cancer.

Chin SP, Dickinson JL, Holloway AF.

Clin Epigenetics. 2011 Aug;2(2):151-69. doi: 10.1007/s13148-011-0041-7. Epub 2011 Jun 14.

13.

Molecular marks for epigenetic identification of developmental and cancer stem cells.

Patra SK, Deb M, Patra A.

Clin Epigenetics. 2011 Apr;2(1):27-53. doi: 10.1007/s13148-010-0016-0. Epub 2010 Dec 17.

14.

Aberrant DNA methylation and prostate cancer.

Majumdar S, Buckles E, Estrada J, Koochekpour S.

Curr Genomics. 2011 Nov;12(7):486-505. doi: 10.2174/138920211797904061.

15.

Dietary factors and epigenetic regulation for prostate cancer prevention.

Ho E, Beaver LM, Williams DE, Dashwood RH.

Adv Nutr. 2011 Nov;2(6):497-510. doi: 10.3945/an.111.001032. Epub 2011 Nov 3. Review.

16.

Epigenetics in prostate cancer.

Albany C, Alva AS, Aparicio AM, Singal R, Yellapragada S, Sonpavde G, Hahn NM.

Prostate Cancer. 2011;2011:580318. doi: 10.1155/2011/580318. Epub 2011 Nov 30.

17.

Global acetylation and methylation changes predict papillary urothelial neoplasia of low malignant potential recurrence: a quantitative analysis.

Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L, Bartels H, Bartels PH, Alberts DS, Montironi R.

Int J Immunopathol Pharmacol. 2011 Apr-Jun;24(2):489-97.

18.

Cancer epigenetics: above and beyond.

Brait M, Sidransky D.

Toxicol Mech Methods. 2011 May;21(4):275-88. doi: 10.3109/15376516.2011.562671. Review.

19.

Cancer epigenetics: linking basic biology to clinical medicine.

Tsai HC, Baylin SB.

Cell Res. 2011 Mar;21(3):502-17. doi: 10.1038/cr.2011.24. Epub 2011 Feb 15. Review.

20.

Nitric oxide: perspectives and emerging studies of a well known cytotoxin.

Paradise WA, Vesper BJ, Goel A, Waltonen JD, Altman KW, Haines GK, Radosevich JA.

Int J Mol Sci. 2010 Jul 16;11(7):2715-45. doi: 10.3390/ijms11072715. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk